Literature DB >> 2891619

Stimulation of superoxide and lactoferrin release from polymorphonuclear leukocytes by the type 2 fimbrial lectin of Actinomyces viscosus T14V.

A L Sandberg1, L L Mudrick, J O Cisar, J A Metcalf, H L Malech.   

Abstract

Polymorphonuclear leukocyte (PMN)-dependent destruction of Actinomyces viscosus T14V is initiated by the recognition of galactose-containing receptors on sialidase-treated PMNs by the lectin associated with the type 2 fimbriae of these bacteria. A. viscosus T14V also stimulates the respiratory burst in PMNs as well as the release of contents of the secondary granules, as determined by the presence of lactoferrin in the culture supernatants. Under the experimental conditions employed, these bacteria do not induce the release of beta-glucuronidase, a constituent of primary granules. None of the three PMN responses studied occurs in cultures containing a mutant of A. viscosus T14V that lacks fimbriae. Activation of the PMNs is mediated by the lectin associated with the type 2 fimbriae, as demonstrated by the finding that beta-linked galactosides inhibit stimulation of the respiratory burst. Thus, the interaction of the Actinomyces fimbrial lectin with its complementary receptors on PMNs results not only in killing of these bacteria but also in the release of reactive oxygen intermediates and enzymes that may be detrimental to surrounding host tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2891619      PMCID: PMC259267          DOI: 10.1128/iai.56.1.267-269.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Isolation and characterization of the alpha-sialyl-beta-2,3-galactosyl-specific adhesin from fimbriated Escherichia coli.

Authors:  T Moch; H Hoschützky; J Hacker; K D Kröncke; K Jann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

2.  Interaction of inflammatory cells and oral microorganisms. IX. the bactericidal effects of human polymorphonuclear leukocytes on isolated plaque microorganisms.

Authors:  S A Passo; C C Tsai; W P McArthur; C Leifer; N S Taichman
Journal:  J Periodontal Res       Date:  1980-09       Impact factor: 4.419

3.  Expression of Actinomyces viscosus antigens in Escherichia coli: cloning of a structural gene (fimA) for type 2 fimbriae.

Authors:  J A Donkersloot; J O Cisar; M E Wax; R J Harr; B M Chassy
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

4.  Gene products specifying adhesion of uropathogenic Escherichia coli are minor components of pili.

Authors:  F Lindberg; B Lund; S Normark
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

5.  Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies.

Authors:  J O Cisar; E L Barsumian; S H Curl; A E Vatter; A L Sandberg; R P Siraganian
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

6.  Structural preferences of beta-galactoside-reactive lectins on Actinomyces viscosus T14V and Actinomyces naeslundii WVU45.

Authors:  F C McIntire; L K Crosby; J J Barlow; K L Matta
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

7.  Stimulation of human polymorphonuclear leukocyte oxidative metabolism by type 1 pili from Escherichia coli.

Authors:  M B Goetz; F J Silverblatt
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

8.  Lectin-dependent attachment of Actinomyces naeslundii to receptors on epithelial cells.

Authors:  M J Brennan; J O Cisar; A E Vatter; A L Sandberg
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.

Authors:  J O Cisar; V A David; S H Curl; A E Vatter
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Type 2 fimbrial lectin-mediated phagocytosis of oral Actinomyces spp. by polymorphonuclear leukocytes.

Authors:  A L Sandberg; L L Mudrick; J O Cisar; M J Brennan; S E Mergenhagen; A E Vatter
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

View more
  8 in total

1.  Cloning and nucleotide sequence of a gene for Actinomyces naeslundii WVU45 type 2 fimbriae.

Authors:  M K Yeung; J O Cisar
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

2.  Resistance of Streptococcus gordonii to polymorphonuclear leukocyte killing is a potential virulence determinant of infective endocarditis.

Authors:  Si Young Lee; John O Cisar; Joseph L Bryant; Michael A Eckhaus; Ann L Sandberg
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

3.  Identification of polymorphonuclear leukocyte and HL-60 cell receptors for adhesins of Streptococcus gordonii and Actinomyces naeslundii.

Authors:  S Ruhl; J O Cisar; A L Sandberg
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

4.  Identification of a gene involved in assembly of Actinomyces naeslundii T14V type 2 fimbriae.

Authors:  M K Yeung; J A Donkersloot; J O Cisar; P A Ragsdale
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

5.  Lectinlike interactions of Fusobacterium nucleatum with human neutrophils.

Authors:  D F Mangan; M J Novak; S A Vora; J Mourad; P S Kriger
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

6.  Specific and nonspecific inhibition of adhesion of oral actinomyces and streptococci to erythrocytes and polystyrene by caseinoglycopeptide derivatives.

Authors:  J R Neeser; A Chambaz; S Del Vedovo; M J Prigent; B Guggenheim
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

7.  Cooperative complement- and bacterial lectin-initiated bactericidal activity of polymorphonuclear leukocytes.

Authors:  C Kurashima; A L Sandberg; J O Cisar; L L Mudrick
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Putative glycoprotein and glycolipid polymorphonuclear leukocyte receptors for the Actinomyces naeslundii WVU45 fimbrial lectin.

Authors:  A L Sandberg; S Ruhl; R A Joralmon; M J Brennan; M J Sutphin; J O Cisar
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.